| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/05/2013 | US20130324574 Treatment of ocular inflammatory diseases using laquinimod |
| 12/05/2013 | US20130324509 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324500 Spinal cord injury, inflammation and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130323327 Method for preventing nasolacrimal duct obstruction |
| 12/05/2013 | US20130323317 Injectable and swellable microspheres for tissue bulking |
| 12/05/2013 | US20130323316 Injectable microspheres for dermal augmentation and tissue bulking |
| 12/05/2013 | US20130323315 Microspheres Including Oxidized Cellulose |
| 12/05/2013 | US20130323314 Novel Nanoparticles of Lactoferrin Useful for Preparing a Pharmaceutical Composition Facilitating Easy Delivery of the Drug and a Process for Preparing the Same |
| 12/05/2013 | US20130323312 Microspheres Including Oxidized Cellulose |
| 12/05/2013 | US20130323311 Collagen-targeted nanoparticles |
| 12/05/2013 | US20130323310 Swellable particles for drug delivery |
| 12/05/2013 | US20130323309 Sustained Release Composition of Memantine |
| 12/05/2013 | US20130323308 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 12/05/2013 | US20130323307 Sildenafil-free base-containing film preparation and method for producing same |
| 12/05/2013 | US20130323306 Injectable biodegradable particles for controlled therapeutic agent release |
| 12/05/2013 | US20130323304 Methods For Enhancing The Release And Absorption of Water Insoluble Active Agents |
| 12/05/2013 | US20130323303 Drug carrier and preparation method thereof |
| 12/05/2013 | US20130323301 Enhanced cancer treatment and monitoring using recombinant vectors |
| 12/05/2013 | US20130323298 Amphoteric Liposome Formulation |
| 12/05/2013 | US20130323297 Local administration of gallium compositions to treat pain |
| 12/05/2013 | US20130323296 Carrier for oromucosal, especially sublingual administration of physiologically active substances |
| 12/05/2013 | US20130323295 Monomer systems with dispersed silicone-based engineered particles |
| 12/05/2013 | US20130323291 Hydrophilic and non-thrombogenic polymer for coating of medical devices |
| 12/05/2013 | US20130323287 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
| 12/05/2013 | US20130323280 Methods for preparing vesicles and formulations produced therefrom |
| 12/05/2013 | US20130323199 Collagen material and method for producing collagen material |
| 12/05/2013 | US20130323189 Antifungal nail coat and method of use |
| 12/05/2013 | US20130323184 Method Of Providing Fast Relief To A User Of A Nicotine Chewing Gum |
| 12/05/2013 | US20130323179 Nanocrystals, compositions, and methods that aid particle transport in mucus |
| 12/05/2013 | US20130323177 Tumor-targeting gas-generating nanoparticle, method for preparing the same, and tumor-targeting nanoparticle for drug delivery using the same |
| 12/05/2013 | US20130323165 Magnetic Nanoplatforms for Theranostic and Multi-Modal Imaging Applications |
| 12/05/2013 | US20130320592 Process for the production of an abuse-proofed dosage form |
| 12/05/2013 | US20130319595 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 12/05/2013 | US20130319411 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases |
| 12/05/2013 | DE102012011034A1 New silicate-phosphate materials useful e.g. as components for optical or optoelectronic applications, preferably glasses with special properties, and for controlled release fertilizers, and as adhesion promoter for coating organic polymers |
| 12/05/2013 | DE102012010774A1 Pharmazeutische Pemetrexed-Lösung Pharmaceutical pemetrexed solution |
| 12/05/2013 | CA2875417A1 O/w-emulsion-type topical pharmaceutical compositions containing a retinoid |
| 12/05/2013 | CA2875229A1 Palatable oral veterinary compositions |
| 12/05/2013 | CA2875208A1 Ph-sensitive carrier and preparation method thereof, and ph sensitive drug and ph sensitive drug composition each containing the carrier, and culture method using the same |
| 12/05/2013 | CA2875193A1 Syringe |
| 12/05/2013 | CA2875150A1 Treatment of solid tumors using coenzyme q10 |
| 12/05/2013 | CA2875146A1 Bioactive agent delivery devices and methods of making and using the same |
| 12/05/2013 | CA2874958A1 New release system of hydrophobic proteins |
| 12/05/2013 | CA2874927A1 Manufacture of degarelix |
| 12/05/2013 | CA2874779A1 Pharmaceutical composition of entecavir and process of manufacturing |
| 12/04/2013 | EP2669289A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application |
| 12/04/2013 | EP2669269A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 12/04/2013 | EP2669002A1 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 12/04/2013 | EP2668961A1 Combined pharmaceutical preparation |
| 12/04/2013 | EP2668952A2 Aqueous formulations of bisphosphonates, vitamin D and benzyl alcohol suitable for subcutaneous or intramuscular use |
| 12/04/2013 | EP2668948A1 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| 12/04/2013 | EP2668943A1 Microspheres including oxidized cellulose |
| 12/04/2013 | EP2668942A1 Microspheres including oxidized cellulose |
| 12/04/2013 | EP2668941A1 Novel dosage form and formulation of abediterol |
| 12/04/2013 | EP2668940A1 Intranasal Administration of Active Agents to the Central Nervous System |
| 12/04/2013 | EP2668939A1 Composition containing polyunsaturated fatty acid |
| 12/04/2013 | EP2668851A1 Liver function-improving agent |
| 12/04/2013 | EP2667917A2 Detachable drug delivery device |
| 12/04/2013 | EP2667884A1 Process for preparation of a herbal extract |
| 12/04/2013 | EP2667879A2 Radiopaque embolic particles |
| 12/04/2013 | EP2667878A1 Compositions and methods for cell transplantation |
| 12/04/2013 | EP2667877A2 Androgen composition for treating an ophthalmic condition |
| 12/04/2013 | EP2667865A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
| 12/04/2013 | EP2667861A2 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same |
| 12/04/2013 | EP2667860A1 Compositions of empty nanoparticles and their use for treating dermatological conditions |
| 12/04/2013 | EP2667859A2 Nanoparticle compositions, formulations thereof, and uses therefor |
| 12/04/2013 | EP2667858A1 Protection of microbial cells from acidic degradation |
| 12/04/2013 | EP2667857A1 A drug delivery device |
| 12/04/2013 | EP2667856A1 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient |
| 12/04/2013 | EP2667855A1 Drug delivery systems |
| 12/04/2013 | EP2667854A1 Nanoparticle compositions |
| 12/04/2013 | EP2667853A1 Liposome and personal care composition comprising thereof |
| 12/04/2013 | EP2667852A1 Adjuvant nanoemulsions with crystallisation inhibitors |
| 12/04/2013 | EP2667851A1 Testosterone formulations |
| 12/04/2013 | EP2667850A1 Maintaining antibody-binding activity of immunosuppressant drug conjugates |
| 12/04/2013 | EP2667849A1 Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections |
| 12/04/2013 | EP2667848A1 Carriers for the local release of hydrophilic prodrugs |
| 12/04/2013 | EP2667844A2 Nanoparticles based for dermal and systemic delivery of drugs |
| 12/04/2013 | EP2667843A2 Nanoparticles based on poly(lactic glycolic) acid for cosmetic applications |
| 12/04/2013 | EP2667842A1 Surfactant compositions |
| 12/04/2013 | EP2667715A1 Treatment of autism spectrum disorderes using glycyl-l-2-methylprolyl-l-glutamic acid |
| 12/04/2013 | EP2552234B1 Spray-dried crystalline active ingredient |
| 12/04/2013 | CN203315382U Senile plaque removal plaster easy and convenient to use |
| 12/04/2013 | CN203315381U Nanometer anti-AIDS (Acquired Immune Deficiency Syndrome) and anti-inflammatory medicament with radiotherapy function |
| 12/04/2013 | CN1997661B Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 12/04/2013 | CN1480212B Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 12/04/2013 | CN103429233A Transdermal delivery system containing galantamine or salts thereof |
| 12/04/2013 | CN103429232A Modified immune-modulating particle |
| 12/04/2013 | CN103429231A Novel preparation of an enteric release system |
| 12/04/2013 | CN103429230A Controlled release tablet of ginkgo biloba extract and procedure for obtaining it |
| 12/04/2013 | CN103429229A Method for producing [delta]-mannitol which can be directly tableted |
| 12/04/2013 | CN103429228A Spray drying vancomycin |
| 12/04/2013 | CN103429227A Nanoparticles delivery systems, preparation and uses thereof |
| 12/04/2013 | CN103429226A Vesicle compositions |
| 12/04/2013 | CN103429225A Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols |
| 12/04/2013 | CN103429224A Pharmaceutical composition for treating disease in oral cavity comprising rebamipide |
| 12/04/2013 | CN103429223A Orally dispersible tablet |
| 12/04/2013 | CN103429222A Microneedle devices and methods |
| 12/04/2013 | CN103429221A A2A antagonists as cognition and motor function enhancers |
| 12/04/2013 | CN103417981A Far infrared medicinal moxibustion substrate, far infrared medicinal moxibustion product containing far infrared medicinal moxibustion substrate and preparation method of far infrared medicinal moxibustion product |